1 |
2cureX AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
2Seventy Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
3-D Matrix Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
4Basebio PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
4D Molecular Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
4Sc AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
89bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
9 Meters Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
A Science AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
AB Science SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
AbCellera Biologics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
Abera Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
Abion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
Abionyx Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
Abivax SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
ABL Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
Abliva AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Absci Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
AC Immune SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
Acceleron Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Achilles Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Aclaris Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
Acticor Biotech SAS (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
Actinium Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Actinogen Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
Active Biotech AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
Acumen Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Acurx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Adagio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
Adalta Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Adaptimmune Therapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Adaptive Biotechnologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
ADC Therapeutics SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
AddLife AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Adial Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Adicet Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
Aditxt Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
ADM Korea Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
ADM Korea Inc (Parent) (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
Adocia SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
Advagene Biopharma Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
Adverum Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
Aeglea Bio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
AEON Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
Aerovate Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Affibody AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
Affimed NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Affinor Growers Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
AFYREN SAS (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
Agalawatte Plantations PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Agile Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Agios Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
AgResearch Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
Aileron Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Akari Therapeutics PLC (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Akero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Akeso Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
Albany Molecular Research, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
Aldeyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
Alector Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
Aligos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
Allarity Therapeutics A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Allarity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Allena Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
Allergy Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
Alligator Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
Allogene Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
Allovir Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Alpha Cognition Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Alphamab Oncology (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Alpine Immune Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
Altamira Therapeutics Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Alterola Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
Alzamend Neuro Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
AlzeCure Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Alzinova AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Ambrx Biopharma Inc - ADR (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
Ambrx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
American Cryostem Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Amniotics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Ampio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Amplia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
AnaptysBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
Anatolia TaniveBytklj Unli Ar Ge SiveTiA (Turkey) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
Anavex Life Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
Anebulo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
AnGes Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Angion Biomedica Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
Annovis Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
Antengene Corporation Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
Anteotech Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Anti Microbial Savior BioteQ Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
Antibe Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
Antisense Therapeutics Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Apellis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
Applied BioCode Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Applied Genetic Technologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
Applied Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
Aprea Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
AptaBio Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
101 |
Aptamer Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
102 |
Aptinyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
103 |
Aqua Bio Technology ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
104 |
Aran Research and Development 1982 Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
105 |
Aravive Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
106 |
ArborGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2010 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
107 |
Arbutus Biopharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
108 |
ArcAroma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
109 |
Arcellx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
110 |
Arch Biopartners Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
111 |
Arcturus Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
112 |
Arcutis Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
113 |
Ardelyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
114 |
Argenica Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
115 |
argenx SE (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
116 |
argenx SE - ADR (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
117 |
Aridis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
118 |
Arix Bioscience PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
119 |
AroCell AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
120 |
Arovella Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
121 |
Arrowhead Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
122 |
Artelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
123 |
Arterra Bioscience SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
124 |
Asarina Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
125 |
Ascelia Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
126 |
Ascendis Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
127 |
Ascentage Pharma Group International (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
128 |
Aslan Pharmaceuticals Ltd (ADR) (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
129 |
Astria Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
130 |
ATAI Life Sciences NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
131 |
Atara Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
132 |
Atea Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
133 |
Athira Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
134 |
Atreca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
135 |
aTyr Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
136 |
Aurinia Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
137 |
Autolus Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
138 |
Avacta Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
139 |
Avalo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
140 |
Avalon Globocare Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
141 |
Avantium NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
142 |
Avecho Biotechnology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
143 |
Avicanna Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
144 |
Avisa Diagnostics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
145 |
Avrobio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
146 |
Axcella Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
147 |
Axonics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
148 |
Axsome Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
149 |
Ayala Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
150 |
BACHEM HOLDING AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
151 |
Bactiquant A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
152 |
Basilea Pharmaceutica AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
153 |
Battelle Memorial Institute (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
154 |
Baudax Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
155 |
Beam Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
156 |
Beijing Sun-Novo Pharma Research Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
157 |
Bellerophon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
158 |
Bellicum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
159 |
Benitec Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
160 |
Benson Hill Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
161 |
Bergenbio ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
162 |
Better Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
163 |
Beyondspring Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
164 |
BGI Genomics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
165 |
Bicycle Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
166 |
Bio Synectics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
167 |
Bio-Path Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
168 |
Bio-Works Technologies AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
169 |
BioArctic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
170 |
biOasis Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
171 |
Bioextrax AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
172 |
Biogend Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
173 |
Biohaven Pharmaceutical Holding Co Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
174 |
BioInfra Life Science Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
175 |
BioInvent International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
176 |
BioLASCO Taiwan Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
177 |
BioLine RX Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
178 |
BioLine RX Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
179 |
Biomea Fusion Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
180 |
Biomind Labs Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
181 |
Biomm SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
182 |
Biomx Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
183 |
Biondvax Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
184 |
Biondvax Pharmaceuticals Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
185 |
BioneerCorp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
186 |
BioNexus Gene Lab Coporation (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
187 |
Bionomics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
188 |
BioNTech SE - ADR (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
189 |
Biophytis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
190 |
BIOQUAL, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
191 |
BioRestorative Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
192 |
Biotron Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
193 |
Biovaxys Technology Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
194 |
Bioventix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
195 |
Biovica International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
196 |
BioVie Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
197 |
BioXcel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
198 |
Bioxyne Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
199 |
Bivictrix Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
200 |
Black Diamond Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
201 |
Blirt SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
202 |
bluebird bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
203 |
Blueprint Medicines Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
204 |
Botanix Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
205 |
BPH Energy Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
206 |
BRAIN Biotech AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
207 |
Braster SA w restrukturyzacji (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
208 |
Briacell Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
209 |
Bright Minds Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
210 |
BrightPath Biotherapeutics Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
211 |
Brii Biosciences Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
212 |
BTC Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
213 |
C4 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
214 |
C4X Discovery Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
215 |
Cabaletta Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
216 |
Caladrius Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
217 |
Callitas Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
218 |
CanBas Co Ltd (Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
219 |
Candel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
220 |
Cannabis Global Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
221 |
Cannabix Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
222 |
Cannasouth Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
223 |
CannPal Animal Therapeutics Ltd. (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
224 |
Cantargia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
225 |
Captor Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
226 |
Cara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
227 |
Carbios SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
228 |
Carbiotix AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
229 |
Cardax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
230 |
Cardiol Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
231 |
Caribou Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
232 |
Carna Biosciences, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
233 |
Cassiopea SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
234 |
Castle Creek Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
235 |
Ceapro Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
236 |
Celcuity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
237 |
Cell MedX Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
238 |
Cellectis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
239 |
Cellectis SA (ADR) (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
240 |
Cellivery Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
241 |
CellSeed Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
242 |
Cellular Biomedicine Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
243 |
Celularity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
244 |
Centessa Pharmaceuticals PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
245 |
Centogene NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
246 |
Century Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
247 |
Cerevel Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
248 |
Chabiotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
249 |
Charles River Laboratories Intl. Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/25/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
250 |
Check Cap Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
251 |
Checkmate Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
252 |
Checkpoint Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
253 |
Chemomab Therapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
254 |
Chemon Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
255 |
ChemPartner PharmaTech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
256 |
Chimerix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
257 |
China Health Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
258 |
Chinook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
259 |
Chiome Bioscience Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
260 |
Cibus Global Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
261 |
Cidara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
262 |
CinCor Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
263 |
Cizzle Biotechnology Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
264 |
Clal Biotechnology Industries Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
265 |
Claritas Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
266 |
Clarity Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
267 |
Clearmind Medicine Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
268 |
Clearside Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
269 |
Clene Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
270 |
Clinuvel Pharmaceuticals Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
271 |
CNS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
272 |
Codexis, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
273 |
Codiak BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
274 |
Cognetivity Neurosciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
275 |
Cognition Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
276 |
CogState Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
277 |
CohBar Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
278 |
Collplant Biotechnologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
279 |
Collplant Biotechnologies Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
280 |
Combigene AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
281 |
Commissrt a l Eng Atmq et x Eg Alts EPIC (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
282 |
COMPASS Pathways PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
283 |
Compass Therapeutics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
284 |
Concert Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
285 |
Connect Biopharma Holdings Ltd (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
286 |
Context Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
287 |
Cortexyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
288 |
Corvus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
289 |
Creative Medical Technology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
290 |
Creo Medical Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
291 |
Crescita Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
292 |
Crinetics Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
293 |
Crispr Therapeutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
294 |
CropLogic Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
295 |
CTC Centro de Tecnologia Canavieira SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
296 |
Cullinan Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
297 |
Curacle Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
298 |
Curasight A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
299 |
CureVac BV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
300 |
CVR Medical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
301 |
Cybin Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
302 |
Cyclerion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
303 |
CymaBay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
304 |
Cynata Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
305 |
Cyteir Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
306 |
Cytogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
307 |
CytomX Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
308 |
CytoTools AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
309 |
D.Western Therapeutics Institute Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
310 |
Decibel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
311 |
Deepmatter Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
312 |
Defence Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
313 |
Dermata Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
314 |
Dextech Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
315 |
DiaMedica Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
316 |
Diamyd Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
317 |
Dice Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
318 |
Dicerna Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
319 |
Diffusion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
320 |
Dimerix Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
321 |
DNA Biomedical Solutions Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
322 |
DNA Chip Research Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
323 |
DNA Link Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
324 |
Double Bond Phrmctcl Intnl AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
325 |
DreamCIS Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
326 |
DV Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
327 |
Dx & Vx Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
328 |
Dyadic International, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
329 |
Dynacure SA (ADR) (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
330 |
Dyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
331 |
e-Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
332 |
Easy Energy Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
333 |
Ecopro HN Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
334 |
Edesa Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
335 |
Edgewise Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
336 |
Effector Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
337 |
Egetis Therapeutics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
338 |
EGF Theramed Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
339 |
Eidos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
340 |
Eiger Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
341 |
Eledon Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
342 |
Elevation Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
343 |
Elicio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
344 |
Eliem Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
345 |
Eloxx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
346 |
Endonovo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
347 |
ENDRA Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
348 |
Energenesis Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
349 |
Enimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
350 |
Enlivex Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
351 |
Enochian Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
352 |
Ensysce Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
353 |
Entera Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
354 |
Entheon Biomedical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
355 |
Eone Diagnomics Genome Center Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
356 |
Epizyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
357 |
EPS Holdings Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
358 |
Erasca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
359 |
Ergomed PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
360 |
Esense-Lab Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
361 |
ESSA Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
362 |
Eurocine Vaccines AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
363 |
Eurofins Scientific SE (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
364 |
Eurofins-Cerep SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
365 |
European Institute of Science AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
366 |
Evaxion Biotech A/S - ADR (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
367 |
Evelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
368 |
Evgen Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
369 |
Evogene Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
370 |
Evolus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
371 |
Evolutionary Genomics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
372 |
Evolva Holding SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
373 |
EXACT Sciences Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
374 |
Exact Therapeutics AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
375 |
Exelixis, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
376 |
Exicure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
377 |
Exopharm Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
378 |
Exscientia PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
379 |
F-Star Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
380 |
Faraday Future Intelligent Electric Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
381 |
Faron Pharmaceuticals Oy (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
382 |
Femtobiomed Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
383 |
FibroGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
384 |
Fiji Kava Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
385 |
Finch Therapeutics Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
386 |
First Wave BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
387 |
Five Prime Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
388 |
Fluicell AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
389 |
Fluoguide AS (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
390 |
Follicum AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
391 |
Foresee Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
392 |
Formycon AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
393 |
Forte Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
394 |
Freeline Therapeutics Holdings PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
395 |
Frequency Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
396 |
Frontage Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
397 |
FSD Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
398 |
FunPep Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
399 |
Fusion Antibodies PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
400 |
Fusion Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
401 |
Futura Medical plc. (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
402 |
G&E Herbal Biotechnology Co., Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
403 |
G1 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
404 |
Gain Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
405 |
Galapagos NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
406 |
Galecto Inc (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
407 |
Galera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
408 |
Galmed Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
409 |
Genematrix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
410 |
Genenta Science SpA(ADR) (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
411 |
Generation Bio Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
412 |
GeNeuro SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
413 |
Genexine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
414 |
Genfit SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
415 |
Genfit SA (ADR) (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
416 |
GenKyoTex SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
417 |
Genmab A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
418 |
Genmab A/S - ADR (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
419 |
Genome&Company (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
420 |
GENOMED SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
421 |
Genomic Vision SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
422 |
Genomics Bioscience & Technology Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
423 |
Genomictree Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
424 |
Genomtec SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
425 |
Genor Biopharma Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
426 |
Genovis AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
427 |
genOway SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
428 |
Genprex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
429 |
Genscript Biotech Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
430 |
Gensight Biologics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
431 |
Genus plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
432 |
Genxone SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
433 |
Geovax Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
434 |
Gevo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
435 |
GFC Green Fields Capital Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
436 |
GH Research PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
437 |
Ginkgo Bioworks Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
438 |
GL Pharm Tech Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
439 |
Global Blood Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
440 |
GlycoMimetics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
441 |
GlycoNex Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
442 |
GNI Group Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
443 |
GNT Biotech & Medicals Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
444 |
Go D M Investments Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
445 |
Goldenwell Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
446 |
Gongwin Biopharm Holdings Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
447 |
Gossamer Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
448 |
Gracell Biotechnologies Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
449 |
Graybug Vision Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
450 |
Greenlight Biosciences Holdings PBC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
451 |
GW Pharmaceuticals PLC- ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
452 |
Gyroscope Therapeutics Holdngs PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
453 |
Hadasit Bio Holding Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
454 |
Hamlet Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
455 |
Hangzhou Bio-sncrty Phrm-tch Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
456 |
Hansa Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
457 |
Harpoon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
458 |
HAVN Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
459 |
Hcw Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
460 |
Healios KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
461 |
Heidelberg Pharma AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
462 |
Helix Biopharma Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
463 |
Hemogenyx Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
464 |
Hemostemix Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
465 |
Hepion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
466 |
Herantis Pharma Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
467 |
Hexima Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
468 |
Hillstream Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
469 |
HitGen Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
470 |
Holista Colltech Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
471 |
Homology Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
472 |
Hua Medicine (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
473 |
Human Metabolome Technologies Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
474 |
Hybrigenics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
475 |
IBEX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
476 |
Ibio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
477 |
iCo Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
478 |
ICON PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
479 |
Icosavax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
480 |
Idogen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
481 |
IDT Australia Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
482 |
Ikena Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
483 |
Imago Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
484 |
Imara Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
485 |
Immatics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
486 |
Immuneering Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
487 |
Immunic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
488 |
Immunicum AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
489 |
Immunitybio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
490 |
Immunocore Holdings PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
491 |
Immunotech Biopharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
492 |
Immunovant Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
493 |
Immunovia AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
494 |
ImmuPharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
495 |
Immutep Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
496 |
Impel Neuropharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
497 |
Imugene Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
498 |
Imv Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
499 |
IN8BIO, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
500 |
Incanthera PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
501 |
Incyte Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
502 |
Indaptus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
503 |
Inflarx NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
504 |
Inhibikase Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
505 |
Inhibitor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
506 |
Inhibrx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
507 |
Initiator Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
508 |
INmune Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
509 |
Innate Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
510 |
Innate Pharma SA (ADR) (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
511 |
Inno-Gene SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
512 |
Innovotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
513 |
Inotiv Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
514 |
Inoviq Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
515 |
Inozyme Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
516 |
Instil Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
517 |
Intech Biopharm Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
518 |
IntegraGen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
519 |
Intellia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
520 |
Intensity Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
521 |
Intervacc AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
522 |
Invap SE (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
523 |
Inventionmed SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
524 |
Inventiva SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
525 |
Invex Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
526 |
Invion Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
527 |
InVitae Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
528 |
IO Biotech Inc (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
529 |
Iovance Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
530 |
Iqvia Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
531 |
Island Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
532 |
ISR Immune System Rgultn Hldg AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
533 |
iTeos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
534 |
Iterum Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
535 |
IVERIC bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
536 |
IXICO PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
537 |
Jacobio Pharmaceuticals Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
538 |
Janone Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/2/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
539 |
Janux Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
540 |
Jasper Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
541 |
Jeevan Scientific Technology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
542 |
Jiangsu Yahong Meditech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
543 |
Joby Aviation Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
544 |
Joinn Laboratories China Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
545 |
Joinn Laboratories China Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
546 |
Jounce Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
547 |
Jupiter Neurosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
548 |
JW (Cayman) Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
549 |
Kadimastem Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
550 |
Kainos Medicine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
551 |
Kalvista Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
552 |
Kamada Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
553 |
Kane Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
554 |
Kang Stem Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
555 |
Karuna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
556 |
Karyopharm Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
557 |
Kazia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
558 |
KBR, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
559 |
KemPharm Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
560 |
Keros Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
561 |
Kezar Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
562 |
Kiadis Pharma NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
563 |
Kidswell Bio Corporation (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
564 |
Kindred Biosciences, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
565 |
Kiniksa Pharmaceuticals Ltd (Bermuda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
566 |
Kinnate Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
567 |
Kintara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
568 |
Kintor Pharmaceutical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
569 |
Kiora Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
570 |
Kiromic Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
571 |
Klaria Pharma Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
572 |
Kodiak Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
573 |
Kolon TissueGene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
574 |
Kringle Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
575 |
Kronos Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
576 |
Krystal Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
577 |
Kuros Biosciences AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
578 |
Kymera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
579 |
Landos Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
580 |
Lantern Pharma Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
581 |
Larimar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
582 |
LAVA Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
583 |
LBT Innovations Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
584 |
Leap Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
585 |
Legend Biotech Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
586 |
Legochem Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
587 |
Lexagene Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
588 |
LianBio - ADR (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
589 |
Lidds AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
590 |
Liminal BioSciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
591 |
Linical Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
592 |
Lipocine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
593 |
Lipum AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
594 |
Liquidia Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
595 |
Living Cell Technologies Ltd. (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
596 |
Longboard Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
597 |
Longeveron Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
598 |
Luminex Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
599 |
Lumosa Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
600 |
Luna Innovations Incorporated (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
601 |
Lyell Immunopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
602 |
Lyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
603 |
Lysogene SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
604 |
Lytix Biopharma AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
605 |
Maat Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
606 |
Mabion SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
607 |
Macrogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
608 |
Magenta Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
609 |
MagForce AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
610 |
Malachite Innovations Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
611 |
Manhattan Scientifics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
612 |
Marinus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
613 |
Marizyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
614 |
Matinas BioPharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
615 |
Mavens Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
616 |
MaxCyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
617 |
Mayo Foundtn fr Medicl Eductn nd Rsrch (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2012 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
618 |
MDxHealth SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
619 |
Meatech 3D Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
620 |
Med Biogene Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
621 |
Medesis Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
622 |
Medicago Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2013 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
623 |
Medical Data Vision Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
624 |
Medicenna Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
625 |
Medicofarma Biotech SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
626 |
Medicure Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
627 |
Medigen Biotechnology Corporation (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
628 |
MediGene AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
629 |
MEDINET CO., LTD. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
630 |
Medipost Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
631 |
Medivir AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
632 |
Medizen Humancare Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
633 |
Medlab Clinical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
634 |
Medpace Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
635 |
Medpacto Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
636 |
MEDRx Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
637 |
Megapro Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
638 |
Mereo BioPharma Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
639 |
Mersana Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
640 |
Merus NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
641 |
Mesoblast limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
642 |
Mesoblast limited (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
643 |
Metacrine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
644 |
Microbix Biosystems Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
645 |
Midatech Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
646 |
Midatech Pharma PLC-ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
647 |
Milestone Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
648 |
Millennium Food Tech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
649 |
Mind Cure Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
650 |
Mind Medicine (MindMed) Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
651 |
Mink Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
652 |
Mirati Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
653 |
Miromatrix Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
654 |
Mirum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
655 |
Modalis Therapeutics Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
656 |
Moderna Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
657 |
Modus Therapeutics Holding AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
658 |
Molecular Partners AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
659 |
Monopar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
660 |
Monte Rosa Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
661 |
Moogene Medi Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
662 |
MorphoSys AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
663 |
Morphosys Ag (ADR) (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
664 |
Motif Bio PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
665 |
Movano Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
666 |
Mustang Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
667 |
Mycotopia Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
668 |
Mydecine Innovations Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
669 |
MyMD Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
670 |
Myokardia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
671 |
Myovant Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
672 |
Nabriva Therapeutics PLC - ADR (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
673 |
NanHua Bio-medicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
674 |
Nanobiotix SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
675 |
NanoCarrier Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
676 |
Nanogroup SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
677 |
Nanosynth Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
678 |
NanoViricides Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
679 |
Nascent Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
680 |
National Research Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
681 |
NatureCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
682 |
Nautilus Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
683 |
Neoimmunetech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
684 |
Neoimmunetech Inc (Parent) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
685 |
Neoleukin Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
686 |
NeonMind Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
687 |
Neovacs SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
688 |
Nerium Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
689 |
Neuren Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
690 |
Neurobo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
691 |
Neuropathix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
692 |
Neuroscientific Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
693 |
Neurosense Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
694 |
Newron Pharmaceuticals SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
695 |
Neximmune Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
696 |
Next Science Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
697 |
Nextage Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
698 |
NextCell Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
699 |
NextCure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
700 |
NGM Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
701 |
Nightingale Health Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
702 |
NKMax Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
703 |
NLS Pharmaceutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
704 |
Nordic Nanovector ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
705 |
Northern Data AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
706 |
Northwest Biotherapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
707 |
NOUL Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
708 |
NOUL Co Ltd (Parent) (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
709 |
Nova Mentis Life Science Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
710 |
Novusterra Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
711 |
NOXXON Pharma NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
712 |
NRX Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
713 |
NuCana PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
714 |
Numinus Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
715 |
Nuvalent Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
716 |
Nuvation Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
717 |
Nuvectis Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
718 |
Nykode Therapeutics AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
719 |
OBI Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
720 |
Obseva SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
721 |
Ocean Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
722 |
Ocular Therapeutix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
723 |
OKYO Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
724 |
Olema Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
725 |
OliX Pharmaceuticals Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
726 |
Omega Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
727 |
Oncodesign SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
728 |
Oncolys Biopharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
729 |
Oncosil Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
730 |
OncoTherapy Science, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
731 |
Open Orphan PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
732 |
Opiant Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
733 |
Opthea Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
734 |
ORIC Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
735 |
Orphazyme A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
736 |
Ortho Regenerative Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
737 |
Oryzon Genomics SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
738 |
Ose Immunotherapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
739 |
Otonomy Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
740 |
Outlook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
741 |
Ovation Science Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
742 |
Ovid Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
743 |
Oxford Biodynamics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
744 |
Oxford BioMedica plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
745 |
Oxurion NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
746 |
Oyster Point Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
747 |
P3 Health Partners Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
748 |
Pacific Edge Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
749 |
Palisade Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
750 |
Pandion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
751 |
Pangaea Oncology SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
752 |
PanGen Biotech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
753 |
Paradigm Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
754 |
Pardes Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
755 |
PAREXEL International Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
756 |
Pascal Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
757 |
Pasithea Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
758 |
Passage Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
759 |
Patrys Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
760 |
PCI Biotech Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
761 |
PDS Biotechnology Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
762 |
Pear Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
763 |
Peijia Medical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
764 |
Peptidream Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
765 |
Peptonic Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
766 |
Personalis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
767 |
Petros Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
768 |
Pharma Mar SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
769 |
PharmAbcine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
770 |
Pharmaceutical Product Development, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2011 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
771 |
Pharmacore Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
772 |
Pharmadax Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
773 |
PharmaEngine Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
774 |
Pharmaron Beijing Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
775 |
Pharmaxis Ltd. (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
776 |
Pharmaxis Ltd. (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
777 |
Pharmigene Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
778 |
Pharvaris NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
779 |
PhaseBio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
780 |
Phathom Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
781 |
Pherecydes Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
782 |
Philogen SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
783 |
PhoenixBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
784 |
Phytohealth Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
785 |
Plant Advanced Technologies PAT SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
786 |
Plantarc Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
787 |
PLx Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
788 |
POINT Biopharma Global Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
789 |
Polaris Group (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
790 |
Poltreg SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
791 |
Pond Technologies Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
792 |
Poseida Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
793 |
Poxel SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
794 |
PPD Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
795 |
PRA Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
796 |
Praxis Precision Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
797 |
Precision BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
798 |
Predictive Technology Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
799 |
Predilife SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
800 |
Prelude Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
801 |
Prestige Biopharma Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
802 |
Prevail Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
803 |
Prometheus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
804 |
Promis Neurosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
805 |
Promore Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
806 |
ProQR Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
807 |
Protagonist Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
808 |
Protara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
809 |
Proteomics International LaboratoriesLtd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
810 |
Psomagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
811 |
Psybio Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
812 |
Psyence Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
813 |
Pulmatrix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
814 |
Pure Biologics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
815 |
Puretech Health PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
816 |
PYC Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
817 |
Qrons Inc (United States) |
FRISK® |
|